Amphastar's Spreading Agent Amphadase Clears FDA

Approval of a 150 unit/mL version could give Amphadase an advantage over Ista's hyaluronidase product Vitrase, which cleared FDA in May but is awaiting approval of a smaller, single-use vial. The enzyme drug has been in shortage since Wyeth discontinued Wydase in 2002.